First Tracks Biotherapeutics Inc (TRAX)
NASDAQ • Healthcare
Last close at September 10, 2026 at 20:00 UTC
Metrics Over Time
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About First Tracks Biotherapeutics Inc
First Tracks Biotherapeutics Inc is a NASDAQ-listed Biotechnology company in the healthcare field that develops immunology-based treatments for autoimmune and inflammatory disorders. The company operates as a clinical-stage therapeutic developer rather than a commercial drug seller, with its work centered on discovering and advancing candidates through human testing.
Today's Snapshot
TRAX closed 4% below yesterday's close, in line with a weaker sector. Trading was lighter than usual, with volume about two-thirds of its usual level.
Trading Volume
Below 10d avg (597.7K)
389K
vs S&P 500 Today
Strong Underperformance
-3.45%
Updated: September 10, 2026 at 20:31 UTC
Get premium market insights delivered directly to your inbox.